DOCSLIB.ORG

Implication of LRRC4C and DPP6 in Neurodevelopmental Disorders Gilles Maussion,1 Cristiana Cruceanu,1,2 Jill A

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Implication of LRRC4C and DPP6 in Neurodevelopmental Disorders Gilles Maussion,1 Cristiana Cruceanu,1,2 Jill A ORIGINAL ARTICLE Implication of LRRC4C and DPP6 in Neurodevelopmental Disorders Gilles Maussion,1 Cristiana Cruceanu,1,2 Jill A. Rosenfeld,3 Scott C. Bell,1 Fabrice Jollant,1,4 Jin Szatkiewicz,5 Ryan L. Collins,6,7 Carrie Hanscom,6 Ilaria Kolobova,1 Nicolas Menjot de Champfleur,8 Ian Blumenthal,6 Colby Chiang,9,10 Vanessa Ota,1 Christina Hultman,11 Colm O’Dushlaine,7 Steve McCarroll,7,12 Martin Alda,13 Sebastien Jacquemont,14 Zehra Ordulu,15,16 Christian R. Marshall,17 Melissa T. Carter,18 Lisa G. Shaffer,3 Pamela Sklar,19 Santhosh Girirajan,20 Cynthia C. Morton,7,21,22 James F. Gusella,6,7,12 Gustavo Turecki,1,2 Dimitri J. Stavropoulos,23 Patrick F. Sullivan,5 Stephen W. Scherer,17,24 Michael E. Talkowski,6,7,25 and Carl Ernst1,2* 1Department of Psychiatry, McGill Group for Suicide Studies, and Douglas Mental Health University Institute, Montreal, Canada 2Department of Human Genetics, McGill University, Montreal, Canada 3Signature Genomic Laboratories, PerkinElmer, Inc., Spokane, Washington 4Nıˆmes Academic Hospital (CHU), Nıˆmes, France 5Department of Genetics, University of North Carolina, Chapel Hill, North Carolina 6Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts 7Broad Institute of MIT and Harvard, Cambridge, Massachusetts 8Department of Neuroradiology, University Hospital Center of Montpellier, Montpellier, France 9Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, Virginia 10McDonnell Genome Institute, Washington University School of Medicine, St. Louis, Missouri 11Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden 12Department of Genetics, Harvard Medical School, Boston, Massachusetts 13Department of Psychiatry Halifax, Dalhousie University, Halifax, Nova Scotia, Canada 14Department of Pediatrics, Sainte-Justine Hospital, University of Montreal, Montreal, Canada 15Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women’s Hospital, Boston, Massachusetts 16Harvard Medical School, Boston, Massachusetts 17The Centre for Applied Genomics and Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Canada 18Regional Genetics Program, The Children’s Hospital of Eastern Ontario, Ottawa, Canada 19Departments of Neuroscience, Psychiatry and Genetics and Genome Sciences, Mount Sinai Hospital, New York, New York 20Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania Gilles Maussion and Cristiana Cruceanu are equally contributing authors. Current address of Jill A. Rosenfeld is Department of Molecular and Human Genetics, Baylor College of Medicine, Houston 77030, TX. Current address of Vanessa Ota is Department of Morphology and Genetics—Genetics Division Federal University of S~ao Paulo—SP 04023-900, Brazil. Current address of Lisa G. Shaffer is Paw Print Genetics, Genetic Veterinary Sciences, Inc., Spokane 99202, WA. Conflicts of interest: The authors declare no conflict of interest. Grant sponsor: Canada Research Chairs program; Grant sponsor: Scottish Rite Charitable Foundation. ÃCorrespondence to: Carl Ernst, Ph.D., Douglas Mental Health University Institute, 6875 LaSalle Boulevard, Frank B. Common Pavilion, Room 2101.2, Verdun H4H 1R3, Quebec, Canada. E-mail: [email protected] Article first published online in Wiley Online Library (wileyonlinelibrary.com): 00 Month 2016 DOI 10.1002/ajmg.a.38021 Ó 2016 Wiley Periodicals, Inc. 1 2 AMERICAN JOURNAL OF MEDICAL GENETICS PART A 21Departments of Obstetrics, Gynecology, and Reproductive Biology and of Pathology, Brigham and Women’s Hospital, and Harvard Medical School, Boston, Massachusetts 22Manchester Academic Health Science Center, University of Manchester, Manchester, United Kingdom 23Genome Diagnostics, Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Canada 24Department of Molecular Genetics and McLaughlin Centre, University of Toronto, Toronto, Canada 25Department of Neurology, Harvard Medical School, Boston, Massachusetts Manuscript Received: 13 April 2016; Manuscript Accepted: 29 September 2016 We performed whole-genome sequencing on an individual from a family with variable psychiatric phenotypes that had a sensory How to Cite this Article: processing disorder, apraxia, and autism. The proband harbored Maussion G, Cruceanu C, Rosenfeld JA, a maternally inherited balanced translocation (46,XY,t(11;14) Bell SC, Jollant F, Szatkiewicz J, Collins RL, LRRC4C (p12;p12)mat) that disrupted , a member of the highly Hanscom C, Kolobova I, de Champfleur specialized netrin G family of axon guidance molecules. The NM, Blumenthal I, Chiang C, Ota V, proband also inherited a paternally derived chromosomal Hultman C, O’Dushlaine C, McCarroll S, DPP6, inversion that disrupted a potassium channel interacting Alda M, Jacquemont S, Ordulu Z, protein. Copy Number (CN) analysis in 14,077 cases with neuro- Marshall CR, Carter MT, Shaffer LG, developmental disorders and 8,960 control subjects revealed Sklar P, Girirajan S, Morton CC, LRRC4C that 60% of cases with exonic deletions in had a second Gusella JF, Turecki G, Stavropoulos DJ, clinically recognizable syndrome associated with variable clini- Sullivan PF, Scherer SW, Talkowski ME, cal phenotypes, including 16p11.2, 1q44, and 2q33.1 CN syn- Ernst C. 2016. Implication of LRRC4C and LRRC4C dromes, suggesting deletion variants may be modifiers DPP6 in neurodevelopmental disorders. of neurodevelopmental disorders. In vitro, functional assess- Am J Med Genet Part A 9999A:1–12. ments modeling patient deletions in LRRC4C suggest a negative regulatory role of these exons found in the untranslated region of LRRC4C, which has a single, terminal coding exon. These data suggest that the proband’s autism may be due to the inheritance a contributor to NDDs and deletions in LRRC4C may be a modifier of disruptions in both DPP6 and LRRC4C, and may highlight the of genetic lesions associated with variable NDD phenotypes. importance of the netrin G family and potassium channel interacting molecules in neurodevelopmental disorders. METHODS Ó 2016 Wiley Periodicals, Inc. Family Recruitment and Assessment Key words: autism; sensory processing; LRRC4C; Netrin G; We obtained blood from all carriers of a BCR identified by DPP6 karyotyping in a multigenerational family (46,XY,t(11;14)(p12; p12)mat), from which the proband, the proband’s mother, and grandmother were available for clinical and genetic testing. Participants or their guardians gave informed consent, using INTRODUCTION consent forms approved by the Douglas Institute Ethics Board. While much progress has been made on the genetics of neuro- The proband was assessed with both the ADOS and ADI as part developmental disorders (NDDs), over 50% of cases assessed clini- of a full clinical work-up done at the Montreal Children’s cally on any genetic platform are considered idiopathic [Krumm Hospital. The mother of the proband confirmed that he met et al., 2014; Sanders et al., 2015]. While more NDD cases would likely criteria for autism on both measures. The mother and the be associated with genetic variation if all cases were assessed using the grandmother of the proband were assessed with the SCID-I full extent of state-of-the-art technology, different strategies need to for Axis-I mental disorders and SCID-II for personality disorders be employed to further unravel the genetics of NDDs. We have according to DSM-IV criteria. Current level of depression was previously shown that balanced chromosomal rearrangement (BCR) assessed by the Beck Depression Inventory and the Hamilton sequencing is a powerful strategy to discover new genes for NDDs Depression Rating Scale (HDRS-24). Cognitive functioning for [Talkowski et al., 2011, 2012c], and here, we report on a child who these two individuals was investigated with the Stroop Color Test inherited two BCRs, one from each parent, each of which disrupted and the Hayling Sentence Completion test for cognitive inhibi- only a single gene: leucine rich repeat containing 4C (LRRC4C [MIM tion, the Trail Making Test (TMT) A and B for flexibility/shifting, 608817]) and dipeptidyl-peptidase 6 (DPP6 [MIM 126141]). Analy- a categorical and semantic verbal fluency test, the National sis of rare copy gains and losses in these genes in thousands of Adult Reading Test (NART) for a raw estimate of verbal IQ, NDD cases suggest that that exon-disrupting CNVs in DPP6 may be the working memory subscale of the WAIS-III, and the Iowa MAUSSION ET AL. 3 Gambling Task (IGT) for decision-making. Individual cognitive and III–2, were read by an experienced radiologist (NM) blinded to performance was then compared to performance from 81 healthy the genetic status of the subjects but aware of their age. A systematic female controls from the GREFEX control group and 72 healthy assessment was run, which included: movement artifacts, atrophy female controls from our own database. (pons, vermian, cortical, corpus callosum), white matter hyper- intensities (infratentorial, cerebellar, pons, dentate nuclei, cerebellar Next Generation Sequencing of BCRs peduncles, mesencephalon, periventricular, deep, juxtacortical, basal ganglia, semi ovale centrum, corticospinal tract, corpus Translocation mapping experiments were performed using cus- callosum), Scheltens and Koedam scores, enlargement (ventricular, tomized large-insert, or “jumping library,” whole genome olfactive sulcus), infarct (territorial, lacunar,
Load more

Recommended publications
  • Molecular Profiling of Peripheral Blood Is Associated with Circulating Tumor Cells Content and Poor Survival in Metastatic Castration-Resistant Prostate Cancer
    www.impactjournals.com/oncotarget/ Oncotarget, Vol. 6, No. 12 Molecular profiling of peripheral blood is associated with circulating tumor cells content and poor survival in metastatic castration-resistant prostate cancer Mercedes Marín-Aguilera1, Òscar Reig1,2, Juan José Lozano3, Natalia Jiménez1, Susana García-Recio1,4, Nadina Erill5, Lydia Gaba2, Andrea Tagliapietra2, Vanesa Ortega2, Gemma Carrera6, Anna Colomer5, Pedro Gascón4 and Begoña Mellado1,2 1 Translational Genomics Group and Targeted Therapeutics in Solid Tumors Group, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain 2 Medical Oncology Department, Hospital Clínic, Barcelona, Spain 3 Bioinformatics Platform Department, Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas y Digestivas (CIBEREHD), Hospital Clínic, Barcelona, Spain 4 Laboratory of Translational Oncology, Fundació Clínic per a la Recerca Biomèdica, Barcelona, Spain 5 Althia, Barcelona, Spain 6 Medical Oncology Department, Hospital Plató, Barcelona, Spain Correspondence to: Begoña Mellado, email: [email protected] Keywords: circulating tumor cells, peripheral blood, microarrays, cell search system Received: January 22, 2015 Accepted: February 14, 2015 Published: March 12, 2015 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT The enumeration of circulating
    [Show full text]
  • An Investigation Into the Genetic Architecture of Multiple System Atrophy and Familial Parkinson's Disease
    An investigation into the genetic architecture of multiple system atrophy and familial Parkinson’s disease By Monica Federoff A thesis submitted to University College London for the degree of Doctor of Philosophy Laboratory of Neurogenetics, Department of Molecular Neuroscience, Institute of Neurology, University College London (UCL) 2 I, Monica Federoff, confirm that the work presented in this thesis is my own. Information derived from other sources and collaborative work have been indicated appropriately. Signature: Date: 09/06/2016 3 Acknowledgements: When I first joined the Laboratory of Neurogenetics (LNG), NIA, NIH as a summer intern in 2008, I had minimal experience working in a laboratory and was both excited and anxious at the prospect of it. From my very first day, Dr. Andrew Singleton was incredibly welcoming and introduced me to my first mentor, Dr. Javier Simon- Sanchez. Within just ten weeks working in the lab, both Dr. Singleton and Dr. Simon- Sanchez taught me the fundamental skills in an encouraging and supportive environment. I quickly got to know others in the lab, some of whom are still here today, and I sincerely appreciate their help with my assimilation into the LNG. After returning for an additional summer and one year as an IRTA postbac, I was honored to pursue a PhD in such an intellectually stimulating and comfortable environment. I am so grateful that Dr. Singleton has been such a wonderful mentor, as he is not only a brilliant scientist, but also extremely personable and approachable. If I inquire about meeting with him, he always manages to make time in his busy schedule and provides excellent guidance and mentorship.
    [Show full text]
  • HIC1 Modulates Prostate Cancer Progression by Epigenetic Modification
    Author Manuscript Published OnlineFirst on January 22, 2013; DOI: 10.1158/1078-0432.CCR-12-2888 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. HIC1 modulates prostate cancer progression by epigenetic modification Jianghua Zheng#1, 2, Jinglong Wang#1, Xueqing Sun#1，Mingang Hao1，Tao Ding3, Dan Xiong 1, Xiumin Wang1, Yu Zhu 4, Gang Xiao 1, Guangcun Cheng1, Meizhong Zhao5, Jian Zhang6, Jianhua Wang1* 1 Department of Biochemistry and Molecular Cell Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. 2 Shanghai Public Health Clinical Center, Fudan University, Shanghai, 201508, China. 3 Department of Urology, Shanghai Putuo Hospital, Shanghai Traditional Chinese Medicine University, Shanghai, 200062, China. 4 Department of Urology, Shanghai Ruijin Hospital, Shanghai, 200025, China. 5 Shanghai Ruijin Hospital, Comprehensive Breast Health Center, Shanghai, 200025, China. 6 Guangxi Medical University, Nanning, 530021, China. # J Zheng, J Wang and X Sun contributed equally to this work. *Corresponding author: Jianhua Wang, PhD, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. Phone: 021-54660871; Fax: 021-63842157; E-mail:[email protected]. No potential conflicts of interest were disclosed 1 Downloaded from clincancerres.aacrjournals.org on October 1, 2021. © 2013 American Association for Cancer Research. Author Manuscript Published OnlineFirst on January 22, 2013; DOI: 10.1158/1078-0432.CCR-12-2888 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Statement of Translational Relevance This study aimed to further our understanding of the role that hypermethylatioted in cancer 1 (HIC1) plays in prostate cancer (PCa) progression.
    [Show full text]
  • Methods in and Applications of the Sequencing of Short Non-Coding Rnas" (2013)
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2013 Methods in and Applications of the Sequencing of Short Non- Coding RNAs Paul Ryvkin University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Bioinformatics Commons, Genetics Commons, and the Molecular Biology Commons Recommended Citation Ryvkin, Paul, "Methods in and Applications of the Sequencing of Short Non-Coding RNAs" (2013). Publicly Accessible Penn Dissertations. 922. https://repository.upenn.edu/edissertations/922 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/922 For more information, please contact [email protected]. Methods in and Applications of the Sequencing of Short Non-Coding RNAs Abstract Short non-coding RNAs are important for all domains of life. With the advent of modern molecular biology their applicability to medicine has become apparent in settings ranging from diagonistic biomarkers to therapeutics and fields angingr from oncology to neurology. In addition, a critical, recent technological development is high-throughput sequencing of nucleic acids. The convergence of modern biotechnology with developments in RNA biology presents opportunities in both basic research and medical settings. Here I present two novel methods for leveraging high-throughput sequencing in the study of short non- coding RNAs, as well as a study in which they are applied to Alzheimer's Disease (AD). The computational methods presented here include High-throughput Annotation of Modified Ribonucleotides (HAMR), which enables researchers to detect post-transcriptional covalent modifications ot RNAs in a high-throughput manner. In addition, I describe Classification of RNAs by Analysis of Length (CoRAL), a computational method that allows researchers to characterize the pathways responsible for short non-coding RNA biogenesis.
    [Show full text]
  • Mitochondrial Protein Quality Control Mechanisms
    G C A T T A C G G C A T genes Review Mitochondrial Protein Quality Control Mechanisms Pooja Jadiya * and Dhanendra Tomar * Center for Translational Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA * Correspondence: [email protected] (P.J.); [email protected] (D.T.); Tel.: +1-215-707-9144 (D.T.) Received: 29 April 2020; Accepted: 15 May 2020; Published: 18 May 2020 Abstract: Mitochondria serve as a hub for many cellular processes, including bioenergetics, metabolism, cellular signaling, redox balance, calcium homeostasis, and cell death. The mitochondrial proteome includes over a thousand proteins, encoded by both the mitochondrial and nuclear genomes. The majority (~99%) of proteins are nuclear encoded that are synthesized in the cytosol and subsequently imported into the mitochondria. Within the mitochondria, polypeptides fold and assemble into their native functional form. Mitochondria health and integrity depend on correct protein import, folding, and regulated turnover termed as mitochondrial protein quality control (MPQC). Failure to maintain these processes can cause mitochondrial dysfunction that leads to various pathophysiological outcomes and the commencement of diseases. Here, we summarize the current knowledge about the role of different MPQC regulatory systems such as mitochondrial chaperones, proteases, the ubiquitin-proteasome system, mitochondrial unfolded protein response, mitophagy, and mitochondria-derived vesicles in the maintenance of mitochondrial proteome and health. The proper understanding of mitochondrial protein quality control mechanisms will provide relevant insights to treat multiple human diseases. Keywords: mitochondria; proteome; ubiquitin; proteasome; chaperones; protease; mitophagy; mitochondrial protein quality control; mitochondria-associated degradation; mitochondrial unfolded protein response 1. Introduction Mitochondria are double membrane, dynamic, and semiautonomous organelles which have several critical cellular functions.
    [Show full text]
  • Haplotype-Sharing Analysis Implicates Chromosome 7Q36 Harboring DPP6 in Familial Idiopathic Ventricular Fibrillation
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector REPORT Haplotype-Sharing Analysis Implicates Chromosome 7q36 Harboring DPP6 in Familial Idiopathic Ventricular Fibrillation Marielle Alders,1,10 Tamara T. Koopmann,2,10 Imke Christiaans,1,3 Pieter G. Postema,3 Leander Beekman,2 Michael W.T. Tanck,4 Katja Zeppenfeld,5 Peter Loh,6 Karel T. Koch,3 Sophie Demolombe,7,8,9 Marcel M.A.M. Mannens,1 Connie R. Bezzina,2 and Arthur A.M. Wilde2,3,* Idiopathic Ventricular Fibrillation (IVF) is defined as spontaneous VF without any known structural or electrical heart disease. A family history is present in up to 20% of probands with the disorder, suggesting that at least a subset of IVF is hereditary. A genome-wide haplo- type-sharing analysis was performed for identification of the responsible gene in three distantly related families in which multiple individuals died suddenly or were successfully resuscitated at young age. We identified a haplotype, on chromosome 7q36, that was conserved in these three families and was also shared by 7 of 42 independent IVF patients. The shared chromosomal segment harbors part of the DPP6 gene, which encodes a putative component of the transient outward current in the heart. We demonstrated a 20-fold increase in DPP6 mRNA levels in the myocardium of carriers as compared to controls. Clinical evaluation of 84 risk-haplotype carriers and 71 noncarriers revealed no ECG or structural parameters indicative of cardiac disease. Penetrance of IVF was high; 50% of risk-haplotype carriers experienced (aborted) sudden cardiac death before the age of 58 years.
    [Show full text]
  • THE FUNCTIONAL SIGNIFICANCE of MITOCHONDRIAL SUPERCOMPLEXES in C. ELEGANS by WICHIT SUTHAMMARAK Submitted in Partial Fulfillment
    THE FUNCTIONAL SIGNIFICANCE OF MITOCHONDRIAL SUPERCOMPLEXES in C. ELEGANS by WICHIT SUTHAMMARAK Submitted in partial fulfillment of the requirements For the degree of Doctor of Philosophy Dissertation Advisor: Drs. Margaret M. Sedensky & Philip G. Morgan Department of Genetics CASE WESTERN RESERVE UNIVERSITY January, 2011 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of _____________________________________________________ candidate for the ______________________degree *. (signed)_______________________________________________ (chair of the committee) ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ (date) _______________________ *We also certify that written approval has been obtained for any proprietary material contained therein. Dedicated to my family, my teachers and all of my beloved ones for their love and support ii ACKNOWLEDGEMENTS My advanced academic journey began 5 years ago on the opposite side of the world. I traveled to the United States from Thailand in search of a better understanding of science so that one day I can return to my homeland and apply the knowledge and experience I have gained to improve the lives of those affected by sickness and disease yet unanswered by science. Ultimately, I hoped to make the academic transition into the scholarly community by proving myself through scientific research and understanding so that I can make a meaningful contribution to both the scientific and medical communities. The following dissertation would not have been possible without the help, support, and guidance of a lot of people both near and far. I wish to thank all who have aided me in one way or another on this long yet rewarding journey. My sincerest thanks and appreciation goes to my advisors Philip Morgan and Margaret Sedensky.
    [Show full text]
  • Mechanisms Underlying Phenotypic Heterogeneity in Simplex Autism Spectrum Disorders
    Mechanisms Underlying Phenotypic Heterogeneity in Simplex Autism Spectrum Disorders Andrew H. Chiang Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy under the Executive Committee of the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2021 © 2021 Andrew H. Chiang All Rights Reserved Abstract Mechanisms Underlying Phenotypic Heterogeneity in Simplex Autism Spectrum Disorders Andrew H. Chiang Autism spectrum disorders (ASD) are a group of related neurodevelopmental diseases displaying significant genetic and phenotypic heterogeneity. Despite recent progress in ASD genetics, the nature of phenotypic heterogeneity across probands is not well understood. Notably, likely gene- disrupting (LGD) de novo mutations affecting the same gene often result in substantially different ASD phenotypes. We find that truncating mutations in a gene can result in a range of relatively mild decreases (15-30%) in gene expression due to nonsense-mediated decay (NMD), and show that more severe autism phenotypes are associated with greater decreases in expression. We also find that each gene with recurrent ASD mutations can be described by a parameter, phenotype dosage sensitivity (PDS), which characteriZes the relationship between changes in a gene’s dosage and changes in a given phenotype. Using simple linear models, we show that changes in gene dosage account for a substantial fraction of phenotypic variability in ASD. We further observe that LGD mutations affecting the same exon frequently lead to strikingly similar phenotypes in unrelated ASD probands. These patterns are observed for two independent proband cohorts and multiple important ASD-associated phenotypes. The observed phenotypic similarities are likely mediated by similar changes in gene dosage and similar perturbations to the relative expression of splicing isoforms.
    [Show full text]
  • Defective NDUFA9 As a Novel Cause of Neonatally Fatal
    Downloaded from http://jmg.bmj.com/ on September 8, 2016 - Published by group.bmj.com New loci ORIGINAL ARTICLE Defective NDUFA9 as a novel cause of neonatally fatal complex I disease B J C van den Bosch,1,2 M Gerards,1,2 W Sluiter,3 A P A Stegmann,1 E L C Jongen,1 D M E I Hellebrekers,1 R Oegema,4 E H Lambrichs,1 H Prokisch,5,6 K Danhauser,5,6 K Schoonderwoerd,4 I F M de Coo,7 H J M Smeets1,2 < An additional table is ABSTRACT patterns. Mutations in nuclear mitochondrial genes published online only. To view Background Mitochondrial disorders are associated with include genes encoding assembly factors, complex this file please visit the journal abnormalities of the oxidative phosphorylation (OXPHOS) subunits of the OXPHOS system, and genes online (http://jmg.bmj.com/ content/49/1.toc). system and cause significant morbidity and mortality in involved in mitochondrial maintenance or metab- the population. The extensive clinical and genetic olism in general.4 Mutations in different genes can 1Department of Clinical Genetics, Unit Clinical heterogeneity of these disorders due to a broad variety lead to similar phenotypes, while mutations in the Genomics, Maastricht University of mutations in several hundreds of candidate genes, same gene can give rise to different phenotypes, Medical Centre, Maastricht, The encoded by either the mitochondrial DNA (mtDNA) or illustrating the clinical and genetic heterogeneity of Netherlands 2 nuclear DNA (nDNA), impedes a straightforward genetic these diseases. Nuclear genes are likely the major School for Oncology and diagnosis.
    [Show full text]
  • Chromosomal Microarray Analysis in Turkish Patients with Unexplained Developmental Delay and Intellectual Developmental Disorders
    177 Arch Neuropsychitry 2020;57:177−191 RESEARCH ARTICLE https://doi.org/10.29399/npa.24890 Chromosomal Microarray Analysis in Turkish Patients with Unexplained Developmental Delay and Intellectual Developmental Disorders Hakan GÜRKAN1 , Emine İkbal ATLI1 , Engin ATLI1 , Leyla BOZATLI2 , Mengühan ARAZ ALTAY2 , Sinem YALÇINTEPE1 , Yasemin ÖZEN1 , Damla EKER1 , Çisem AKURUT1 , Selma DEMİR1 , Işık GÖRKER2 1Faculty of Medicine, Department of Medical Genetics, Edirne, Trakya University, Edirne, Turkey 2Faculty of Medicine, Department of Child and Adolescent Psychiatry, Trakya University, Edirne, Turkey ABSTRACT Introduction: Aneuploids, copy number variations (CNVs), and single in 39 (39/123=31.7%) patients. Twelve CNV variant of unknown nucleotide variants in specific genes are the main genetic causes of significance (VUS) (9.75%) patients and 7 CNV benign (5.69%) patients developmental delay (DD) and intellectual disability disorder (IDD). were reported. In 6 patients, one or more pathogenic CNVs were These genetic changes can be detected using chromosome analysis, determined. Therefore, the diagnostic efficiency of CMA was found to chromosomal microarray (CMA), and next-generation DNA sequencing be 31.7% (39/123). techniques. Therefore; In this study, we aimed to investigate the Conclusion: Today, genetic analysis is still not part of the routine in the importance of CMA in determining the genomic etiology of unexplained evaluation of IDD patients who present to psychiatry clinics. A genetic DD and IDD in 123 patients. diagnosis from CMA can eliminate genetic question marks and thus Method: For 123 patients, chromosome analysis, DNA fragment analysis alter the clinical management of patients. Approximately one-third and microarray were performed. Conventional G-band karyotype of the positive CMA findings are clinically intervenable.
    [Show full text]
  • WO 2017/070647 Al 27 April 2017 (27.04.2017) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2017/070647 Al 27 April 2017 (27.04.2017) P O P C T (51) International Patent Classification: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, A61K 31/455 (2006.01) C12N 15/86 (2006.01) KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, A61K 31/465 (2006.01) A61P 27/02 (2006.01) MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, A61K 31/19 (2006.01) A61P 27/06 (2006.01) OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, A61K 48/00 (2006.01) A61K 45/06 (2006.01) SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (21) International Application Number: ZW. PCT/US2016/058388 (84) Designated States (unless otherwise indicated, for every (22) International Filing Date: kind of regional protection available): ARIPO (BW, GH, 24 October 2016 (24.10.201 6) GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, (25) Filing Language: English TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, (26) Publication Language: English DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, (30) Priority Data: LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, 62/245,467 23 October 2015 (23.
    [Show full text]
  • Electron Transport Chain Activity Is a Predictor and Target for Venetoclax Sensitivity in Multiple Myeloma
    ARTICLE https://doi.org/10.1038/s41467-020-15051-z OPEN Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma Richa Bajpai1,7, Aditi Sharma 1,7, Abhinav Achreja2,3, Claudia L. Edgar1, Changyong Wei1, Arusha A. Siddiqa1, Vikas A. Gupta1, Shannon M. Matulis1, Samuel K. McBrayer 4, Anjali Mittal3,5, Manali Rupji 6, Benjamin G. Barwick 1, Sagar Lonial1, Ajay K. Nooka 1, Lawrence H. Boise 1, Deepak Nagrath2,3,5 & ✉ Mala Shanmugam 1 1234567890():,; The BCL-2 antagonist venetoclax is highly effective in multiple myeloma (MM) patients exhibiting the 11;14 translocation, the mechanistic basis of which is unknown. In evaluating cellular energetics and metabolism of t(11;14) and non-t(11;14) MM, we determine that venetoclax-sensitive myeloma has reduced mitochondrial respiration. Consistent with this, low electron transport chain (ETC) Complex I and Complex II activities correlate with venetoclax sensitivity. Inhibition of Complex I, using IACS-010759, an orally bioavailable Complex I inhibitor in clinical trials, as well as succinate ubiquinone reductase (SQR) activity of Complex II, using thenoyltrifluoroacetone (TTFA) or introduction of SDHC R72C mutant, independently sensitize resistant MM to venetoclax. We demonstrate that ETC inhibition increases BCL-2 dependence and the ‘primed’ state via the ATF4-BIM/NOXA axis. Further, SQR activity correlates with venetoclax sensitivity in patient samples irrespective of t(11;14) status. Use of SQR activity in a functional-biomarker informed manner may better select for MM patients responsive to venetoclax therapy. 1 Department of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory University, Atlanta, GA, USA.
    [Show full text]